| Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide … A Lievre, A Turpin, I Ray-Coquard, K Le Malicot, J Thariat, G Ahle, ... European Journal of Cancer 141, 62-81, 2020 | 151 | 2020 |
| Induction chemotherapy followed by cetuximab radiotherapy is not superior to concurrent chemoradiotherapy for head and neck carcinomas: results of the GORTEC 2007-02 phase III … L Geoffrois, L Martin, D De Raucourt, XS Sun, Y Tao, P Maingon, J Buffet, ... Journal of Clinical Oncology 36 (31), 3077-3083, 2018 | 149 | 2018 |
| Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised … XS Sun, Y Tao, C Le Tourneau, Y Pointreau, C Sire, MC Kaminsky, ... The Lancet Oncology 21 (9), 1173-1187, 2020 | 101 | 2020 |
| A rationale for chemoradiation (vs radiotherapy) in salivary gland cancers? On behalf of the REFCOR (French rare head and neck cancer network) T Cerda, XS Sun, S Vignot, PY Marcy, B Baujat, AC Baglin, AM Ali, ... Critical reviews in oncology/hematology 91 (2), 142-158, 2014 | 88 | 2014 |
| Cervical and vaginal cancer associated with pessary use S Schraub, XS Sun, PH Maingon, JC Horiot, N Daly, R Keiling, J Pigneux, ... Cancer 69 (10), 2505-2509, 1992 | 73 | 1992 |
| LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 … J Bourhis, C Sire, Y Tao, L Martin, M Alfonsi, JB Prevost, M Rives, ... Annals of Oncology 31, S1168, 2020 | 71 | 2020 |
| Improved outcome by adding concurrent chemotherapy to cetuximab and radiotherapy for locally advanced head and neck carcinomas: results of the GORTEC 2007-01 phase III … Y Tao, A Auperin, C Sire, L Martin, C Khoury, P Maingon, E Bardet, ... Journal of Clinical Oncology 36 (31), 3084-3090, 2018 | 69 | 2018 |
| LBA35 Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III … J Bourhis, Y Tao, X Sun, C Sire, L Martin, X Liem, A Coutte, Y Pointreau, ... Annals of Oncology 32, S1310, 2021 | 66 | 2021 |
| Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 … Y Tao, J Biau, XS Sun, C Sire, L Martin, M Alfonsi, JB Prevost, A Modesto, ... Annals of Oncology 34 (1), 101-110, 2023 | 64 | 2023 |
| A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN … XS Sun, C Sire, Y Tao, L Martin, M Alfonsi, JB Prevost, M Rives, C Lafond, ... Journal of Clinical Oncology 36 (15_suppl), 6018-6018, 2018 | 64 | 2018 |
| Subcutaneous interleukin-2 and interferon alfa administration in patients with metastatic renal cell carcinoma: final results of SCAPP III, a large, multicenter, phase II … JM Tourani, C Pfister, N Tubiana, M Ouldkaci, G Prevot, V Lucas, ... Journal of clinical oncology 21 (21), 3987-3994, 2003 | 58 | 2003 |
| Avelumab–cetuximab–radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial … Y Tao, A Aupérin, X Sun, C Sire, L Martin, A Coutte, C Lafond, J Miroir, ... European journal of cancer 141, 21-29, 2020 | 56 | 2020 |
| Phase II study of vinorelbine in patients with androgen-independent prostate cancer S Oudard, A Caty, Y Humblet, M Beauduin, E Sue, M Piccart, F Rolland, ... Annals of oncology 12 (6), 847-852, 2001 | 53 | 2001 |
| Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques XS Sun, SR Sun, N Guevara, PY Marcy, I Peyrottes, S Lassalle, A Lacout, ... Critical reviews in oncology/hematology 86 (1), 52-68, 2013 | 42 | 2013 |
| Chemoradiation in anaplastic thyroid carcinomas XS Sun, SR Sun, N Guevara, N Fakhry, PY Marcy, S Lassalle, I Peyrottes, ... Critical Reviews in Oncology/Hematology 86 (3), 290-301, 2013 | 40 | 2013 |
| Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC XS Sun, C Michel, E Babin, D De Raucourt, A Péchery, E Gherga, B Géry, ... Future Oncology 14 (9), 877-889, 2018 | 35 | 2018 |
| Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell … Y Tao, A Auperin, P Blanchard, M Alfonsi, XS Sun, M Rives, Y Pointreau, ... Radiotherapy and Oncology 150, 18-25, 2020 | 24 | 2020 |
| PET-based prognostic survival model after radiotherapy for head and neck cancer J Castelli, A Depeursinge, A Devillers, B Campillo-Gimenez, Y Dicente, ... European journal of nuclear medicine and molecular imaging 46, 638-649, 2019 | 24 | 2019 |
| Avelumab-cetuximab-radiotherapy (RT) versus standards of care (SoC) in locally advanced squamous cell carcinoma of the head and neck (SCCHN): Safety phase of the randomized … Y Tao, A Auperin, XS Sun, C Sire, L Martin, G Bera, A Coutte, J Miroir, ... Journal of Clinical Oncology 36 (15_suppl), 6076-6076, 2018 | 23 | 2018 |
| Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial TAO Yungan, XS Sun, Y Pointreau, C Le Tourneau, C Sire, MC Kaminsky, ... European journal of cancer 183, 24-37, 2023 | 22 | 2023 |
